Not independent
Tenure on this board
13.8 yrs
9 nominees · 3 ballot items.
Approve issuance of shares upon exercise of warrants from June 8, 2026 financing and repriced warrants; approve reverse stock split at a 1-for-5 to 1-for-70 ratio; authorize adjournment(s) to solicit additional proxies if needed.
Approve issuance of up to 2,396,709 shares upon exercise of warrants issued in the June 8, 2026 financing and certain repriced outstanding warrants, in compliance with Nasdaq Rule 5635(d).
This management proposal requests shareholder approval under Nasdaq Listing Rule 5635(d) to issue up to 2,396,709 shares upon exercise of warrants issued in a financing that closed June 8, 2026 and certain repriced outstanding warrants. Management sought approval because Nasdaq treats warrants as having value when determining whether an issuance exceeds thresholds requiring shareholder approval; to avoid the Warrants being exercisable without approval, the company structured them so exercise is conditioned on obtaining shareholder approval. Approval enables the company to receive up to roughly $18.3 million in potential cash proceeds if warrant holders cash-exercise (including Series C, D, and Placement Agent Warrants), supporting working capital and operations; failure to approve would leave warrants non-exercisable and force repeated shareholder votes every 60 days, imposing costs and management distraction. The risks include dilution to existing shareholders (2,396,709 shares) and potential downward pressure on stock price from increased float; the Series C Warrants include a one-time exercise price reset tied to any reverse split and Series D Warrants include a zero-cash exercise that could increase dilution without cash proceeds. The Board unanimously recommends a vote FOR to permit the company access to the proceeds, maintain compliance with Nasdaq procedures, and reduce recurring solicitation burdens; shareholders should weigh the funding benefits against dilution and market-impact risks.
Approve amendment to the Certificate of Incorporation to permit a reverse split of common stock at a ratio between 1-for-5 and 1-for-70, to be determined by the Board within 12 months if approved, to help maintain Nasdaq listing compliance.
This management proposal seeks shareholder authorization to amend the Certificate of Incorporation to permit the Board, within 12 months of approval, to implement a reverse stock split at a ratio between 1-for-5 and 1-for-70. Management is requesting broad ratio approval to provide flexibility to select an appropriate split ratio in response to market conditions and Nasdaq listing requirements, notably the minimum bid price standard; the Board retains discretion to abandon the reverse split if not in stockholders’ best interests. The reverse split aims to increase the per-share trading price and help maintain Nasdaq Capital Market listing, potentially avoiding delisting consequences that could impair liquidity, fundraising ability, and valuations. The proposal will affect outstanding securities, including reducing outstanding shares and adjusting conversion/exercise prices for options, warrants, and convertible preferred stock, and may lead to fractional-share cash-outs; anti-takeover concerns arise because the number of authorized shares remains unchanged, increasing available authorized but unissued shares for future issuance. Expected benefits include regained compliance with Nasdaq and improved market perception, but risks include possible adverse market reaction, reduced liquidity, odd-lot holdings, and potential dilution from future issuances enabled by increased authorized but unissued shares. The Board unanimously recommends a vote FOR to preserve listing status and financing flexibility, while shareholders should weigh the short-term administrative and fractional-share impacts against longer-term listing benefits.
Authorize the Board to adjourn the Special Meeting one or more times to solicit additional proxies if there are insufficient votes to approve Proposals 1 or 2.
This management proposal asks shareholders to grant the Board authority to adjourn the Special Meeting one or more times (for periods under 30 days) to solicit additional proxies if Proposals 1 or 2 lack sufficient votes at the scheduled meeting. The action is procedural and designed to preserve the record date and allow already-submitted proxies to be voted at any reconvened meeting without re-noticing, thereby minimizing administrative burden and avoiding the need for repeated mailings. Approval facilitates the company’s ability to complete essential corporate actions (notably the Warrant Exercise and potential Reverse Split) by providing time to obtain additional shareholder support. The Board recommends FOR because it believes this preserves shareholder value by enabling completion of matters without further delay; risks are minimal but include potential additional solicitation costs and temporary postponement of final outcomes. The vote standard is a majority of shares present and entitled to vote; abstentions count as negative votes. The Board unanimously recommends a vote FOR.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 8.8% | 236,200 | $248K |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 43,406 | $46K |
| 3 | Tower Research Capital LLC (TRC | 0.2% | 5,189 | $5K |
| 4 | CITIGROUP INC | 0.2% | 5,126 | $5K |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 0.0% | 770 | $808 |
| 6 | SBI Securities Co., Ltd. | 0.0% | 63 | $66 |
| 7 | UBS Group AG | 0.0% | 45 | $47 |
| 8 | Caitong International Asset Management Co., Ltd | 0.0% | 4 | $4 |
| 9 | UBS Group AG | 0.0% | 1 | $1 |
| 10 | Ankerstar Wealth, LLC | 0.0% | 1 | $1 |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.